Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 649-655

  Tinel, Marina ^a   Elkahwaji, Johny ^a   Robin, Marie Anne ^a   Fardel, Nicolas ^a   Descatoire, Veronique ^a   Haouzi, Delphine ^a   Berson, Alain ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BUTYRIC ACID; CYTOCHROME P450; DIMETHYL SULFOXIDE; GENISTEIN; INTERLEUKIN 2 RECEPTOR; ISOENZYME; MYC PROTEIN; RECOMBINANT INTERLEUKIN 2; RETINOIC ACID;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME REPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; LIVER CELL; MALE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; REACTION TIME;

ANIMALS; BLOTTING, NORTHERN; BUTYRIC ACID; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DIMETHYL SULFOXIDE; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; LIVER; LYMPHOCYTES; MALE; OLIGONUCLEOTIDES, ANTISENSE; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; TRETINOIN;

EID: 0032927193     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. Antonson P, Pray MG, Jacobsson A and Xanthopoulos KG (1995) Myc inhibits CCAAT/enhancer-binding protein α-gene expression in HIB-1B hybernoma cells through interactions with the core promoter region. Eur J Biochem 232:397-403.
3. Asao H, Tanaka N, Ishii N, Higuchi M, Takeshita T, Nakamura M, Shirasawa T and Sugamura K (1994) Interleukin 2-induced activation of JAK3: Possible involvement in signal transduction for c-myc induction and cell proliferation. FEBS Lett 351:201-206.
4. Buggs C, Nasrin N, Mode A, Tollet P, Zhao HF, Gustafsson JA and Bridges MA (1998) IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPα (CCAAT/enhancer-binding protein α)-stimulated expression of the sex-specific cytochrome P450 2C12 gene. Mol Endocrinol 12:1294-1309.
5. Chaouchi N, Wallon C, Taieb J, Auffredou MT, Tertian G, Lemoine FM, Delfraissy JF and Vasquez A (1994) Interferon-α-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: Role of bcl-2 and c-myc. Clin Immunol Immunopathol 73:197-204.
6. Chen JQ, Ström A, Gustafsson JA and Morgan ET (1995) Suppression of the constitutive expression of cytochrome P450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 47:940-947.
7. Craig PI, Tapner M and Farrell GC (1993) Interferon suppresses erythromycin metabolism in rats and human subjects. Hepatology 17:230-235.
8. Dony C, Kessel M and Gruss P (1985) Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature (London) 317:636-639.
9. Elkahwaji J, Robin MA, Berson A, Tinel M, Lettéron P, Labbe G, Beaune P, Elias D, Rougier P, Escudier B, Duvillard P and Pessayre D (1999) Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol, in press.
10. Escriou N, Jankovic DL and Thèse J (1992) Interleukin-1 and interleukin-6 synergize in preparing murine B cells to respond to anti-μ: Correlation with c-myc expression. Cellular Immunol 141:243-252.
11. Fujiwara Y, Monden M, Mori T, Nakamura Y and Emi M (1993) Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 53:857-860.
12. Georgakopoulos E, McMenamin M and Skouteris GG (1996) Phospholipase A2 is activated by tumor necrosis factor-α in primary hepatocytes stimulated by a deleted form of hepatocyte growth factor. Biochem Biophys Res Commun 217: 1263-1270.
13. Habib SL, Srikanth NS, Scappaticci FA, Faletto MB, Maccubbin A, Farber E, Ghosal AK and Gurtoo HL (1994) Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy. Toxicol Appl Pharmacol 124:139-148.
14. Hayashi K, Makino R, Kawamura H, Arisawa A and Yoneda K (1987) Characterization of rat c-myc and adjacent regions. Nucleic Acids Res 15:6419-6436.
15. Heruth DP, Zirnstein GW, Bradley JF and Rothberg PG (1993) Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 268:20466-20472.
16. Holt JT, Redner RL and Nienhuis AW (1988) An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol 8:963-973.
17. Jover R, Bort R, Gomez-Lechon MJ and Castell JV (1998) Re-expression of C/EBP alpha induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells. FEBS Lett 431:227-230.
18. Kovacs EJ, Oppenheim JJ and Young HA (1986) Induction of c-fos and c-myc expression in T lymphocytes after treatment with recombinant interleukin 1-α. J Immunol 137:3649-3651.
19. Krumm A, Meulia T, Brunvand M and Groudine M (1992) The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev 6:2201-2213.
20. Li LH, Nerlov C, Prendegast G, MacGregor D and Ziff EB (1994) c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J 13:4070-4079.
21. Liddle C, Murray M and Farrell GC (1989) Effect of liver regeneration on hepatic cytochrome P450 isozymes and serum sex steroids in the male rat. Gastroenterology 96:864-872.
22. Lomo J, Smeland EB, Stokke T, Holte H, Funderud S and Blomhoff HK (1991) Differential effects of interferon-γ and low molecular weight BCGF on growth of human B lymphocytes: Interferon-γ prolongs the increased c-MYC mRNA levels after activation. Scand J Immunol 83:365-373.
23. Lotze MT, Matory YL, Ettinghausen SE, Rayner AA, Sharrow SO, Seipp CAY, Custer MC and Rosenberg SA (1985) In vivo administration of purified human interleukin 2. II. Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J Immunol 135:2865-2875.
24. Luc PV, Adesnik M, Ganguly S and Shaw PM (1996) Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins. Biochem Pharmacol 51:345-356.
25. Mink S, Mutschler B, Weiskirchen R, Bister K and Klempnauer KH (1996) A novel function for Myc: Inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci USA 93:6635-6640.
26. Mischoulon D, Rana B, Bucher NLR and Farmer SR (1992) Growth-dependent inhibition of CCAAT enhancer-binding protein (C/EBPα) gene expression during hepatocyte proliferation in the regenerating liver and in culture. Mol Cell Biol 12:2553-2560.
27. Nelson BH, Lord JD and Greenberg PD (1994) Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T cell proliferation. Nature (London) 239:333-336.
28. lck to β-chain of interleukin-2 receptor in human natural killer (NK)-rich cells and decreased NK-mediated cytotoxicity. Proc Soc Exp Biol Med 207:227-233.
29. Ourlin JC, Jounaïdi Y, Maurel P and Vilarem MJ (1996) Role of the liver-enriched transcription factors C/EBPα and DBP in the expression of human CYP3A4 and CYP3A7. J Hepatol 26 (Suppl 2):54-62.
30. Robin MA, Maratrat M, Le Roy M, Le Breton FP, Bonierbale E, Dansette P, Ballet F, Mansuy D and Pessayre D (1996) Antigenic targets in tienilic acid hepatitis: Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera. J Clin Invest 98:1471-1480.
31. Roy AL, Carruthers C, Gutjahr T and Roeder RG (1993) Direct role for c-myc in transcription initiation mediated by interactions with TFII-1. Nature (London) 365:359-361.
32. Scanlon KJ, Ohta Y, Ishida H, Kijima H, Ohkawa T, Kaminski A, Tsai J, Horng G and Kashani-Sabet M (1995) Oligonucleotide-mediated modulation of mammalian gene expression. FASEB J 9:12888-12896.
33. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonette RP and Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Wash DC) 257:212-214.
34. Strobl LJ and Eick D (1992) Hold back of RNA polymerase II at the transcription start site mediates down-regulation of c-myc in vivo. EMBO J 11:3307-3314.
35. Thai C, El Kahwaji J, Loeper J, Tinel M, Doostzadeh J, Labbe G, Leclaire J, Beaune P and Pessayre D (1994) Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat. J Pharmacol Exp Ther 268:515-521.
36. Tinel M, Robin MA, Doostzadeh J, Maratrat M, Ballet F, Fardel N, El Kahwaji J, Beaune P, Daujat M, Labbe G and Pessayre D (1995) The interleukin-2 receptor down-regulates the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 109:1589-1599.
37. Trinchieri G (1989) Biology of natural killer cells. Adv Immunol 147:187-376.
38. Waldmann TA (1993) The IL-2/IL-2 receptor system: A target for rational immune intervention. Immunol Today 14:264-270.
39. Westin EH, Wong-Staal F, Gelmann EP, Favera RD, Papas T, Lautenberger JA, Eva A, Reddy P, Tronick SR, Aaronson SA and Gallo RC (1982) Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci USA 79:2490-2494.
40. Wiebel FJ, Park SS, Kiefer F and Gelboin HV (1984) Expression of cytochromes P450 in rat hepatoma cells: Analysis by monoclonal antibodies specific for cytochromes P450 from rat liver induced by 3-methylcholanthrene or phenobarbital. Eur J Biochem 145:455-462.